Skip to content
  • GLOBAL
  • US
Merlin Global Logo
  • Physicians
  • Patients
  • Resources
  • Publications
  • About
  • News
  • Contact
  • Order a Test

News & Press

News & Presskari.sharp@gmail.com2025-03-26T12:09:24-07:00

Press Releases

  • SkylineDx Announces that CP-GEP (Merlin CP-GEP) is Now Recognized by the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) as a Predictive GEP Test That May be Used in Select Cutaneous Melanoma Patients to Assess Metastatic Risk

    Feb 19, 2026

    Read More

  • SkylineDx Publishes Landmark MERLIN_001 Trial in JAMA Surgery Validating the Predictive Power of the Merlin CP-GEP Test in Melanoma

    Oct 22, 2025

    Read More

  • SkylineDx’s Merlin Melanoma Assay shows its ability to reduce SLNB by over 40% in a Danish Multicenter Validation Study

    Jul 22, 2025

    Read More
12Next
Merlin logo
  • Physicians
  • Patients
  • Resources
  • Publications
  • About
  • News
  • Contact
  • Order a Test

Connect with us
and get the latest news and insights about Merlin

SkylineDx BV | Brainpark II – Building XI | Lichtenauerlaan 40 | 3062ME Rotterdam | The Netherlands

© 2026 SkylineDx BV | All Rights Reserved
Privacy Policy | Terms of Use
Page load link

YOU ARE ABOUT TO ENTER A MERLIN TEST SPECIFIC SECTION

Please be aware that the information you have requested is intended for the residents of a specific country or countries. The country specific rules and legislation apply to this section. As a result, these webpages related to the Merlin Test may contain information that are not applicable to your county or region.

Do you wish to continue to the US section?

Yes
No
Go to Top